Development of a lozenge for oral transmucosal delivery of trans-resveratrol in humans: proof of concept.

Development of a lozenge for oral transmucosal delivery of trans-resveratrol in humans: proof of concept.

Resveratrol provides multiple physiologic benefits which promote healthspan in various model species and clinical trials support continued exploration of resveratrol treatment in humans. However, there remains concern regarding low bioavailability and wide inter-individual differences in absorption...

Full description

Bibliographic Details
Main Authors: Otis L Blanchard, Gregory Friesenhahn, Martin A Javors, James M Smoliga
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3935991?pdf=render

Similar Items

Similar Items